TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

8.10$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement BIOA
Line item 2013 2014 2015 2016 2017 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
100.9% 391.7% 120.3% 165.2% 149.4% 2.4%
-0.9% -291.7% -20.3% -65.2% -49.4% 100.0%
622.1% 982.2% 934.0% 87.0% 36.6% 822.3%
188.6% 400.1% 303.5% 79.1% 69.7% 309.2%
1,544.2% 1,989.8% 1,753.6% 293.0% 686.8% 1,131.5%
-1,545.1% -2,281.5% -1,773.9% -358.2% -736.2% -1,031.5%
278.9% 7.7%
-1,264.0% -3,060.3% -1,895.7% -342.6% -683.3% -896.1%
3.9% 4.9% -0.2% 0.3% 0.5%
-1,246.3% -3,008.5% -1,713.9% -271.7% -656.8% -896.1%
-1,457.4% -2,915.0% -1,522.6% -160.7% -593.7% -886.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?